The antibody treatment seems to be effective against the omicron variant:
Thursday its Covid-19 antibody treatment, approved in the U.K. Thursday, appears to be effective against the omicron variant of coronavirus, according to early data from laboratory studies, as fears grow over whether existing treatments and vaccines are less potent against the highly-mutated variant.
Sotrovimab “retains activity against key mutations” of the new variant, GSK said, and tests are underway to ensure the antibody therapy is still effective against all omicron mutations.approved sotrovimab, marketed as Xevudy, for use in patients with mild-to-moderate Covid-19 at risk of severe illness.
The U.K.’s drugs regulator, the Medicines and Healthcare products Regulatory Agency , said a clinical trial showed a single dose of the treatment reduced the risk of hospitalisation and death by 79% in high-risk adults with symptomatic Covid-19 infection and was most effective when taken soon after the onset of symptoms.
The agency said it will work with GSK and Vir to establish the antibody treatment’s effectiveness against omicron. George Scangos, Vir chief executive, said sotrovimab was “designed with a mutating virus in mind,” targeting a part of the virus’ spike protein that is less likely to mutate. Scangos said he thought future variants of coronavirus “would be inevitable” and that he is confident the treatment will work against “the full combination” of mutations of omicron.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
UK Approves Covid Antibody Treatment That's Likely Effective Against Omicron—Here's What To KnowI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Les mer »
COVID-19 Antibody Drug Likely Works Against Omicron, Companies SayEarly lab studies show that a COVID-19 antibody treatment developed by GlaxoSmithKline and Vir Biotechnology could be effective against the Omicron variant.
Les mer »
Factbox: What COVID-19 vaccine and drug makers have to say about OmicronThe Omicron variant of the coronavirus has sparked fears that existing COVID-19 vaccines and treatment could be less effective against it.
Les mer »
Glaxo’s Covid-19 Antibody Drug Found to Be Effective Against OmicronThe antibody treatment was effective against the variant in early laboratory studies, setting it apart from similar therapies that appear to work less well against the highly mutated strain.
Les mer »
Moderna Warns of ‘Material Drop’ in Vaccine Efficacy Against OmicronThe Moderna CEO says existing COVID-19 vaccines will likely be less effective against the new Omicron variant. “I think it’s going to be a material drop,” he said. “I just don’t know how much, because we need to wait for the data.'
Les mer »
GSK says tests indicate antibody drug works against OmicronLaboratory analysis of the antibody-based COVID-19 therapy GlaxoSmithKline (GSK) is developing with U.S. partner Vir has indicated the drug is effective against the new Omicron variant, the British drugmaker said on Thursday.
Les mer »